Abacavir/dolutegravir/lamivudine (Triumeq)

Abacavir reverse transcriptase inhibitor

Dolutegravir integrase inhibitor

Lamivudine nucleoside analog reverse transcriptase inhibitors

Abacavir/dolutegravir/lamivudine (trade name Triumeq) is a fixed-dose combination drug for the treatment of HIV/AIDS.

It is a combination of three drugs with different and complementary mechanisms of action: abacavir, a reverse transcriptase inhibitor, dolutegravir an integrase inhibitor, and lamivudine, a nucleoside analog reverse transcriptase inhibitor.

Leave a Reply

Your email address will not be published. Required fields are marked *